Cannabinoids that are acidic (CBGA, CBDA and others)

 CBGA is the mother cannabinoid in the cannabis plant's life cycle, and it serves as a precursor to CBDA Bulk and CBCA. These so-called acidic cannabinoids are not classified as prohibited substances.

As a result, harvesting hemp early gives larger quantities of CBGA and CBG than later in the plant's life, when there are lower levels unless the cultivar has been genetically designed to effectively inhibit the transformation of CBGA into later developing cannabinoids during the plant's development. The biological and chemical processes in the hemp plant reveal that decarboxylated forms of acidic such as CBGA, CBDA Bulk, and CBCA are transformed into CBG, CBD, and CBC. In the olivetol series, the cannabinoid CBCA can continue to transform — first becoming CBC, then CBL, and finally CBT. CBCA predominates in young plants and normally decreases as the plant ages.

While they are not widely available commercially, the acidic precursors of CBD, CBC, and CBG are becoming more popular in the creation of health and wellness products. Decarboxylation converts acidic cannabis into neutral forms during processing (high temperatures). To preserve these acids, a very cautious temperature-controlled extraction technique must be used. Cold solvent extraction, such as cryo ethanol, permits the acids to be preserved.

Science studies are now reporting that the acids have therapeutic benefits that outperform their neutral counterparts, and forward-thinking consumers and consumer product companies are looking for reliable supply chains for highly concentrated CBDA (cannabidiolic acid), CBGA (cannabigerol acid), and CBCA (cannabichromene acid) extracts.

CBDA, CBGA, and CBCA Have Therapeutic Potential

The acidic cannabinoids are still mostly unknown, and further scientific research is needed to discover their full medicinal potential. According to one study, there is a need to lessen nausea and vomiting in cancer patients undergoing chemotherapy. For example, CBD has been found in animal models to minimize expected nausea, but CBD was not nearly as effective as CBDA Isolate For Sale, revealing a distinct therapeutic potential for this cannabinoid that is activating a receptor in the body that has been known for its therapeutic potential.CBDA and CBGA may also have a role in diabetes control by reducing the activity of enzymes involved in diabetes. In fact, acidic cannabinoids inhibit this enzyme more than neutral cannabinoids.

CBGA and CBDA have also been shown to be cytotoxic against colon cancer. More scientists and researchers are expected to investigate the health and wellness benefits of acidic cannabinoid precursors and their neutral counterparts in novel ratios and formulations, resulting in a surge in demand for these compounds in the supply chain industry.